Inactivated Vaccines Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Are the Primary Drivers Supporting the Market Growth of theInactivated Vaccines Market?
The rising instances of infectious diseases are anticipated to fuel the inactivated vaccine market’s expansion in the future. Infectious diseases, which can be transmitted from one individual to another, are health issues prompted by pathogens like bacteria, fungi, viruses, or parasites. They cause a variety of symptoms and health issues, with tuberculosis being one such infectious ailment. Non-living pathogens are employed in inactivated vaccines to trigger an immune response, effectively safeguarding against diseases like polio, influenza, and hepatitis A. For example, there was a surge in the number of tuberculosis patients in the USA shown by data from the Centers for Disease Control and Prevention, a national public health agency in the US. The number rose from 8,320 in 2022 to 9,615 in 2023, a spike of 1,295 cases. Consequently, the escalation in infectious diseases is spurring the expansion of the inactivated vaccine market. An expected acceleration in immunization initiatives is set to propel the inactivated vaccines market’s growth further. Immunization initiatives are coordinated campaigns aimed at vaccinating individuals or communities against specific infectious diseases, which are key factors in inactivated vaccines. Amplified efforts in vaccination result in an increased demand for inactivated vaccines, thereby stimulating market growth and driving investments in research and development. For example, the World Health Organization, a Switzerland-based intergovernmental organization, reported in July 2023 that vaccines prohibit 4-5 million lives worldwide from being lost to infectious diseases such as hepatitis, diphtheria, tetanus, pertussis, measles, and polio every year. Furthermore, in 2022, approximately 84% of infants worldwide were administered three doses of the polio vaccine. In the same year, an estimated 84% of infants in countries utilizing the oral polio vaccine (OPV) were given their first dose of the inactivated polio vaccine (IPV). Thus, the growth in immunization initiatives is facilitating the expansion of the inactivated vaccines market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp
#How Will the CAGR of the Inactivated Vaccines Market Influence Its Overall Growth by 2034?
The market size for inactivated vaccines has seen consistent growth in the past few years. This market is projected to increase from $6.19 billion in 2024 to $6.44 billion in 2025, representing a compound annual growth rate (CAGR) of 4.0%. Factors such as polio eradication initiatives, influenza immunization campaigns, newly emerging infectious diseases, and regulatory authorizations have contributed to the growth observed in the historic period.
The market size of inactivated vaccines is predicted to witness consistent expansion in the upcoming years, reaching an estimated value of $7.75 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 4.7%. This growth during the forecast period can be associated with factors like readiness for pandemics, greater vaccine coverage, progress in biomanufacturing, and initiatives for health equality. Important trends expected during this forecast period include mRNA vaccine platforms, combination vaccines, thermostable vaccines, and digital vaccine passports.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13018
What Are the Latest Innovations Influencing theInactivated Vaccines Market?
Leading enterprises in the inactivated vaccines market are developing and launching innovative inactivated vaccines to maintain their market dominance. An inactivated vaccine encompasses inactivated virus particles, bacteria, or any other pathogens cultivated in a lab and subsequently exterminated to eliminate their ability to cause diseases. For instance, in January 2022, GSK PLC, a biotechnology and pharmaceutical company based in the UK, introduced a novel inactivated vaccine called Shingrix to aid in the prevention of shingles (Herpes zoster). Shingrix is an adjuvanted, non-live, recombinant subunit vaccine administered via two intramuscular injections. Initially, the vaccine was intended for those aged 50 and above. However, its coverage has recently been extended to individuals who are 18 years and older, particularly vulnerable to shingles due to immune deficiencies or because of immunosuppression induced by a diagnosed disease or treatment.
Who Are the Major Industry Players Accelerating Growth in theInactivated Vaccines Market?
Major companies operating in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., .
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Which Primary Segments of the Inactivated Vaccines Market Are Driving Growth and Industry Transformations?
The inactivated vaccines market covered in this report is segmented –
1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
Subsegments:
1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine
2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13018&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theInactivated Vaccines Market?# Market?
North America was the largest region in the inactivated vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Inactivated Vaccines Market 2025, By The Business Research Company:
Veterinary Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
Cancer Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report
Companion Animal Veterinary Vaccines Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
